Action Eurofins Scientific - ERF

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

39,47 Plage de 52 semaines 60,72

Cap du marché

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

432 292

Actions en circulation

192 981 000

Rendement du Dividende

Ratio Cours sur Bénéfices

28,69

Bénéfice par action (BPA)

2,11

Chiffre d'affairess

6,97B

Bénéfice net

406,4M

Secteur

Testing Laboratories

Industrie

Testing Laboratories

Site Web

www.eurofins.com

Siège social

Grand Duche Du, Lux

Fondé

Eurofins Scientific SE est coté dans le secteur Testing Laboratories de la Euronext avec le ticker ERF. Le dernier cours de clôture d'Eurofins Scientific était de -. Au cours de la dernière année, les actions de Eurofins Scientific ont été négociées dans une fourchette de prix de 39,47 € à 60,72 €.

Eurofins Scientific compte actuellement 192 981 000 actions en circulation. Eurofins Scientific a un ratio cours/bénéfice (ratio PE) de 28.69.

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: This replaces the announcement made at 1:56 PM CEST on May 3 due to the following corrections: "Exercise of stock options and...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in...

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and...

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Regulatory News: EUROFINS SCIENTIFIC SE (Paris:ERF): Les actionnaires de la Société, et uniquement avec voix consultative les porteurs de...

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins (Paris:ERF): Eurofins Genomics wird Our Future Health, das bislang größte Gesundheitsforschungsprogramm des Vereinigten Königreichs...

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins (Paris : ERF) : Eurofins Genomics est fier d'annoncer son soutien à Our Future Health, le plus grand programme de recherche en santé...

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Regulatory News: ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and...

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

Regulatory News: Eurofins Scientific (Paris:ERF): Financial Highlights Eurofins delivered a very strong performance in FY 2021, exceeding all...

Période	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	57.62	60.72	56.34	274765	58.40294795	DE
4	54.34	60.72	54.32	381968	57.57867799	DE
12	49.42	60.72	45.56	432292	53.41757884	DE
26	47.84	60.72	45.56	409948	51.31962721	DE
52	54	60.72	39.47	419353	50.42047891	DE
156	82.4	83.2	39.47	393251	57.68574753	DE
260	570	754	39.47	349127	73.33097814	DE

ERF - Frequently Asked Questions (FAQ)

What is the current Eurofins Scientific share price?

The current share price of Eurofins Scientific is 0,00 €

How many Eurofins Scientific shares are in issue?

Eurofins Scientific has 192 981 000 shares in issue

What is the 1 year trading range for Eurofins Scientific share price?

Eurofins Scientific has traded in the range of 39,47 € to 60,72 € during the past year

What is the PE ratio of Eurofins Scientific?

The price to earnings ratio of Eurofins Scientific is 28,69

What is the cash to sales ratio of Eurofins Scientific?

The cash to sales ratio of Eurofins Scientific is 1,67

What is the reporting currency for Eurofins Scientific?

Eurofins Scientific reports financial results in EUR

What is the latest annual turnover for Eurofins Scientific?

The latest annual turnover of Eurofins Scientific is EUR 6,97B

What is the latest annual profit for Eurofins Scientific?

The latest annual profit of Eurofins Scientific is EUR 406,4M

What is the registered address of Eurofins Scientific?

The registered address for Eurofins Scientific is 23 VAL FLEURI, GRAND DUCHE DU, L-1526

What is the Eurofins Scientific website address?

The website address for Eurofins Scientific is www.eurofins.com

Which industry sector does Eurofins Scientific operate in?

Eurofins Scientific operates in the TESTING LABORATORIES sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ALCHIAlchimie	0,55 € (292,86%)	609,52k
ALMCPMcphy Energy	0,14 € (70,73%)	2,03M
ALCBICrypto Blockchain Industries	1,00 € (65,56%)	4,43M
ALGBEGlobal Bioenergies	0,091 € (44,44%)	2,42M
MLWEYWeya	0,0155 € (40,91%)	5k
ALNEVNeovacs	0,002 € (-16,67%)	16,77M
BOLD21Shares AG	37,3825 (-13,33%)	130
ALDEVDevernois Sa	10,40 € (-11,11%)	15
ALAMAAMA Corporation PLC	0,242 € (-10,70%)	44,77k
ALRPDRapid Nutrition	0,0086 € (-10,42%)	13,1M
ALCYBCybergun	0,0004 € (0,00%)	290,17M
ALALOAcheterLouerFR	0,0004 € (0,00%)	190,75M
BCPBanco Comercial Portugues SA	0,6714 € (-0,47%)	58,99M
ALHPIHopium SA	0,0004 € (0,00%)	46,54M
ALSRSSirius Media	0,0029 € (7,41%)	27,15M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Eurofins Scientific SE (ERF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Eurofins Scientific SE

ERF Dernières nouvelles

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Eurofins Scientific SE (ERF) Cours

Eurofins Scientific SE (ERF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Eurofins Scientific SE

ERF Dernières nouvelles

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Connectez-vous

Supprimer les publicités